Value-based health care is getting popular these days as providers are paid on the basis of patient health outcomes. As healthcare options for patients to get sophisticated, healthcare providers are focusing on the quality of treatment and research that satisfies patients.
One such new research study reveals that patients who suffer from osteoarthritis and take nonsteroidal anti-inflammatory drugs (NSAIDs) are at risk for cardiovascular disease. The risk is twice the rate than general population faces. NSAIDs are used to treat osteoarthritis patients who suffer from stiff joints, especially in the morning.
When the cartilage in joints thin, bones rub against each other. This leads to common symptoms like joint swelling and pain. Aslam Anis, Ph.D., from the University of British Columbia in Vancouver, Canada said that there is no cure for osteoarthritis patients. You have to treat the pain. But, when it is treated with NSAIDs, cardiovascular risk increases.
Its already proved that osteoarthritis patient is at risk for cardiovascular disease. But, Anis and his colleagues conducted this study as they wanted to disentangle the role of NSAI in the case of osteoarthritis patients.